DNA甲基转移酶3B-149C>T多态性与致癌风险相关性的Meta分析

doi:10.3969/j.issn.1004-616x.2019.02.003

癌变·畸变·突变 ›› 2019, Vol. 31 ›› Issue (2): 102-110.doi: 10.3969/j.issn.1004-616x.2019.02.003

DNA甲基转移酶3B-149C>T多态性与致癌风险相关性的Meta分析

吴雯^1,2, 李萍^2,3, 左然^1,2, 曾庆波^2,4, 吴德生², 谢妮³, 龙鼎新¹, 袁建辉^1,4,5

1. 南华大学公共卫生学院, 湖南衡阳 421001;
2. 深圳市疾病预防控制中心毒理研究所, 广东深圳 518055;
3. 深圳市第二人民医院转化医学研究院, 广东深圳 518000;
4. 中山大学公共卫生学院, 广东广州 510080;
5. 深圳市南山区疾病预防控制中心, 广东深圳 518054

收稿日期:2018-12-20 修回日期:2019-03-07 出版日期:2019-03-30 发布日期:2019-03-30
通讯作者: 龙鼎新,E-mail:dxlong99@163.com;袁建辉,E-mail:jianhui_yuan@126.com E-mail:dxlong99@163.com;jianhui_yuan@126.com
作者简介:吴雯,E-mail:wuwen_zxy@126.com。
基金资助:
广东省自然科学基金（2017A030313668）；深圳市科技创新委员会（JCYJ20160328161613864，JSGG20170414104216477）

Correlation between polymorphism of DNA methyltransferase 3B-149C>T and cancer risk:a meta-analysis

WU Wen^1,2, LI Ping^2,3, ZUO Ran^1,2, ZENG Qingbo^2,4, WU Desheng², XIE Ni³, LONG Dingxin¹, YUAN Jianhui^1,4,5

1. School of Public Health, University of South China, Hengyang 421001, Hunan;
2. Institute of Toxicology, Shenzhen Center for Disease Control and Prevention, Shenzhen 518055;
3. Institute of Translation Medicine, Shenzhen Second People's Hospital, Shenzhen 518000;
4. School of Public Health, Sun Yat-sen University, Guangzhou 510080;
5. Shenzhen Nanshan District Center for Disease Control and Prevention, Shenzhen 518054, Guangdong, China

Received:2018-12-20 Revised:2019-03-07 Online:2019-03-30 Published:2019-03-30

摘要/Abstract

摘要： 目的：评估DNA甲基转移酶3B-149C > T （DNMT3B-149C > T）多态性与致癌风险之间的相关性。方法：依据Newcastle-Ottawa Scale （NOS）文献质量评价量表，对1990~2017年国内外公开发表的相关文献进行评价并提取资料；对DNMT3B-149C > T各基因型模型进行比较，包括CC与TT、CT与TT、CC+CT与TT，综合分析其在病例组和对照组中的分布情况；通过Q检验和I²值分析各研究间的异质性，应用Begg秩相关法和Egger回归法验证发表偏倚，使用Review Manager 5.0软件和STATA version 12.0进行统计分析，计算比值比（OR）及95%置信区间（95%CI），评估DNMT3B-149C>T多态性与致癌风险的相关性。结果：分析文献中的7 612名癌症病例和9 679名健康对照。按不同癌症类型进行亚组分析，DNMT3B-149C > T多态性与肺癌的患病存在相关性[OR=1.51，95%CI（1.08，2.12），P=0.02]。结论：DNMT3B-149C > T多态性可能是肺癌的易感性因素。

关键词: DNA甲基转移酶3B, 单核苷酸多态性, 癌症, Meta分析, 肺癌

Abstract: OBJECTIVE:To assess the associations between polymorphism of DNA methyltransferase 3B-149C > T (DNMT3B-149C > T) and cancer risk.METHODS:We evaluated and extracted the relevant literatures published from 1990 to 2017 based on Newcastle-Ottawa Scale (NOS).All genotype models of DNMT3B-149C > T were compared,including CC and TT,CT and TT,CC+CT and TT,and their distillations in case and control groups were comprehensively analyzed.Q-test and I2 value were used to analyze the heterogeneity among the studies.Begg and Egger regressions were used to verify the evaluation of publication bias,and Review Manager 5.0 and STATA version 12.0 software were used for Meta-analysis.The correlation between polymorphism of DNMT3B-149C > T and cancer risk was calculated by using the odds ratio (OR) and 95% confidence interval (95% CI).RESULTS:7 612 cancer cases and 9 679 healthy controls in the literature were analyzed.According to subgroup analysis of different cancer types,the DNMT3B-149C>T polymorphism was associated with lung cancer[OR=1.51,95%CI(1.08,2.12),P=0.02].CONCLUSION:DNMT3B-149C > T polymorphism may be a susceptibility factor for lung cancer.

Key words: DNA methyltransferase 3B, polymorphism, cancer, meta-analysis, lung cancer

中图分类号:

R730.2

吴雯, 李萍, 左然, 曾庆波, 吴德生, 谢妮, 龙鼎新, 袁建辉. DNA甲基转移酶3B-149C>T多态性与致癌风险相关性的Meta分析[J]. 癌变·畸变·突变, 2019, 31(2): 102-110.

WU Wen, LI Ping, ZUO Ran, ZENG Qingbo, WU Desheng, XIE Ni, LONG Dingxin, YUAN Jianhui. Correlation between polymorphism of DNA methyltransferase 3B-149C>T and cancer risk:a meta-analysis[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(2): 102-110.

参考文献

[1] MOSTOWSKA A,SAJDAK S,PAWLIK P,et al. DNMT1,DNMT3A and DNMT3B gene variants in relation to ovarian cancer risk in the Polish population[J]. Mol Biol Rep,2013,40(8):4893-4899.
[2] SINGAL R,DAS P M,MANOHARAN M,et al. Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk[J]. Oncol Rep,2005,14(2):569-573.
[3] SUCCI M,DE CASTRO T B,GALBIATTI A L S,et al. DNMT3B C46359T and SHMT1 C1420T polymorphisms in the folate pathway in carcinogenesis of head and neck[J]. Mol Biol Rep,2013,41(2):581-589.
[4] 刘东声,张淑红,胡嘉波,等. DNMT3B基因启动子C46359T多态性与食管癌易感性的关联分析[J]. 东南大学学报(医学版),2008,27(5):319-323.
[5] LIU Z,WANG L,WANG LE,et al. Polymorphisms of the DNMT3B gene and risk of squamous cell carcinoma of the head and neck:A case-control study[J]. Cancer Lett,2008,268(1):158-165.
[6] FAN H,ZHANG F,HU J,et al. Promoter polymorphisms of DNMT3B and the risk of colorectal cancer in Chinese:a case-control study[J]. J Exp Clin Cancer Res,2008,27(1):24.
[7] EFTEKHAR E,RASTI M,NAHGIBALHOSSAINI F,et al. The Study of DNA Methyltransferase-3B Promoter Variant Genotype among Iranian Sporadic Breast Cancer Patients[J]. Iran J Med Sci,2014,39(3):268-274.
[8] SHEN H B,WANG L,SPITZ M R,et al. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer[J]. Cancer Res,2002,62(17):4992-4995.
[9] ZHU J,DU S,ZHANG J,et al. Polymorphism of DNA methyltransferase 3B-149C/T and cancer risk:a meta-analysis[J]. Med Oncol,2015,32(1):399.
[10] ZHU S,ZHANG H,TANG Y,et al. DNMT3B polymorphisms and cancer risk:a meta analysis of 24 case-control studies[J]. Mol Biol Rep,2012,39(4):4429-4437.
[11] MANDAL R K,HAQUE S,WAHID M,et al. Meta-analysis reveals no association of DNMT3B-149 C>T gene polymorphism with overall cancer risk[J]. Curr Genomics,2016,17(6):528-537.
[12] WELLS G A,SHEA B J,O'CONNELL D,et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis[J]. Appl Eng Agric,2014,18(6):727-734.
[13] EGGER M,DAVEY SMITH G,SCHNEIDER M,et al. Bias in meta-analysis detected by a simple,graphical test[J]. Bmj,1997,315(7109):629-634.
[14] MOHER D,LIBERATI A,TETZLAFF J,et al. Preferred reporting items for systematic reviews and meta-analyses:the prisma statement[J]. J Clin Epidemiol,2009,62(10):1006-1012.
[15] 李渊,戴悦,武淑兰,等. DNMT3B基因启动子单核苷酸多态性C46359T与急性白血病的关系[J]. 中华内科杂志,2005,44(8):588-591.
[16] ZHANG X M,LI S,ZHANG Q M. DNA methyltransferase 3B-149C/T polymorphism and the risk of laryngeal squamous cell carcinoma:a case-control study[J]. Genet Mol Res,2015,14(4):12866-12871.
[17] 杨明. DNMT3B基因多态性与非小细胞肺癌易感性的关系研究[D]. 长春:吉林大学,2008.
[18] 张淑红,杨琳红,马雪梅,等. DNMT3B基因SNP(-149C/T)与佳木斯地区肺癌发病风险的关系[J]. 中国老年学,2011,31(21):4090-4092.
[19] GAO M,HE D,MENG F,et al. Associations of DNMT3B-149C>T and -2437T>A polymorphisms and lung cancer risk in Chinese population[J]. World J Surg Oncol,2016,14(1):293.
[20] LAI C Y,HUANG C C,TSAI C H,et al. The DNA Methyltransferase 3B-149 genetic polymorphism modulates lung cancer risk from smoking[J]. Asian Pac J Cancer P,2017,18(10):2717-2723.
[21] 张淑红. DNA甲基转移酶3B启动子区SNP位点与胃癌发病风险的相关性研究[D]. 佳木斯:佳木斯大学,2008.
[22] 刘东声. DNMT3A/3B基因启动子区SNPs与胃癌、食管癌遗传易感性的研究[D]. 南京:东南大学,2009.
[23] HU J,FAN H,LIU D,et al. DNMT3B promoter polymorphism and risk of gastric cancer[J]. Digest Dis Sci,2009,55(4):1011-1016.
[24] JONES J S. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset[J]. Cancer Epidem Biomar,2006,15(5):886-891.
[25] REEVES S G,MOSSMAN D,MELDRUM C J,et al. The -149C>T SNP within the ΔDNMT3B gene,is not associated with early disease onset in hereditary non-polyposis colorectal cancer[J]. Cancer Lett,2008,265(1):39-44.
[26] DE VOGEL S,WOUTERS K A D,GOTTSCHALK R W H,et al. Genetic variants of methyl metabolizing enzymes and epigenetic regulators:associations with promoter CpG island hypermethylation in colorectal cancer[J]. Cancer Epidem Biomar,2009,18(11):3086-3096.
[27] IACOPETTA B,HEYWORTH J,GIRSCHIK J,et al. TheMTHFRC677T and ΔDNMT3B C-149T polymorphisms confer different risks for right-and left-sided colorectal cancer[J]. Int J Cancer,2009,125(1):84-90.
[28] KARPINSKI P,MYSZKA A,RAMSEY D,et al. Polymorphisms in methyl-group metabolism genes and risk of sporadic colorectal cancer with relation to the CpG island methylator phenotype[J]. Cancer Epidemiol,2010,34(3):338-344.
[29] BAO Q,HE B,PAN Y,et al. Genetic variation in the promoter of DNMT3B is associated with the risk of colorectal cancer[J]. Int J Colorectal Dis,2011,26(9):1107-1112.
[30] NAGHIBALHOSSAINI F,MOKARRAM P,KHALILI E,et al. DNMT3b-149C/T promoter variants and methylation of colorectal cancer-associated genes[J]. Cancer Biomark,2015,15(3):227-233.
[31] WU Y,LIN J S. DNA methyltransferase 3B promoter polymorphism and its susceptibility to primary hepatocellular carcinoma in the Chinese Han nationality population:A case-control study[J]. World J Gastroentero,2007,13(45):6082-6086.
[32] EZZIKOURI S,EL FEYDI A E,BENAZZOUZ M,et al. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population[J]. Infect Genet Evol,2009,9(5):877-881.
[33] LAO Y,WU H,ZHAO C,et al. Promoter polymorphisms of DNA methyltransferase 3B and risk of hepatocellular carcinoma[J]. Biomed Rep,2013,1(5):771-775.
[34] MONTGOMERY K G,LIU M C P,ECCLES D M,et al. The DNMT3B C→T promoter polymorphism and risk of breast cancer in a British population:a case-control study[J]. Breast Cancer Res,2004,6(4):R390-R394.
[35] 迪力夏提·金斯汗,赵倩,吐鲁洪·沙列尔,等. DNA甲基化酶3b多态性与乳腺癌易感性的关系[J]. 中国老年学杂志,2017,37(5):1151-1154.
[36] HERNáNDEZ-SOTELO D,GARCíA-AGUILAR R,CASTRO-CORONEL Y,et al. The 46359CT polymorphism of DNMT3B is associated with the risk of cervical cancer[J]. Mol Biol Rep,2013,40(7):4275-4280.
[37] HO V,ASHBURY J E,TAYLOR S,et al. Genetic and epigenetic variation in the DNMT3B and MTHFR genes and colorectal adenoma risk[J]. Environ Mol Mutagen,2016,57(4):261-268.
[38] LIN R K,HSU H S,CHANG J W,et al. Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer[J]. Lung Cancer,2007,55(2):205-213.

DNA甲基转移酶3B-149C>T多态性与致癌风险相关性的Meta分析

Correlation between polymorphism of DNA methyltransferase 3B-149C>T and cancer risk:a meta-analysis

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	郑建涛, 杨勇, 周东. 基于TCGA数据分析CX43表达在胶质瘤中的临床意义及其与免疫细胞浸润的关系[J]. 癌变·畸变·突变, 2021, 33(4): 250-254,261.
[2]	刘晓霞, 李卫霞, 李志加, 苏镇军, 段晓辉, 韩维文, 王云晓, 贺晓磊, 吕林林, 贾金海. 血清谷胱甘肽过氧化物酶与晚期非小细胞肺癌患者临床病理指标及预后的相关性[J]. 癌变·畸变·突变, 2021, 33(4): 286-290,295.
[3]	王熙凯, 孟庆贺, 高燕鲁. miR-223-3p通过调控ECT2诱导非小细胞肺癌细胞凋亡的实验研究[J]. 癌变·畸变·突变, 2021, 33(3): 187-192.
[4]	赵俊伟, 华辰凤, 尚平平, 谢复炜, 李翔. 亚砷酸As (Ⅲ)诱导人肺癌A549细胞氧化应激反应的实验研究[J]. 癌变·畸变·突变, 2021, 33(1): 28-31.
[5]	赵子慧, 王绪华. 非小细胞肺癌伴随诊断的研究进展[J]. 癌变·畸变·突变, 2021, 33(1): 66-71,76.
[6]	郭茜晨, 张婷婷, 王润新, 赵法明, 盛夏. 内质网应激反应IRE1α信号通路与细胞衰老在癌症中的作用及关系的研究进展[J]. 癌变·畸变·突变, 2021, 33(1): 72-76.
[7]	刘晓霞, 李卫霞, 苏镇军, 贾金海, 段晓辉, 李志加, 贺晓磊, 吕林林, 刘睿, 王云晓. 晚期非小细胞肺癌病理特征及放化疗联合治疗疗效与患者血清超氧化物歧化酶的关系[J]. 癌变·畸变·突变, 2020, 32(5): 350-354.
[8]	邵俊国, 焦文静, 王雪晓, 张金艳, 马鸣. miR-429和Bmi-1 mRNA在肺癌组织中的表达及其临床意义[J]. 癌变·畸变·突变, 2020, 32(5): 369-373.
[9]	吕燕萍, 吴传城, 杨双凤, 何陈周, 韩仁杰, 颜伟, 刘宝英. 胃癌差异表达miRNA及其相关基因的单核苷酸多态性与胃癌预后的相关性研究[J]. 癌变·畸变·突变, 2020, 32(5): 380-386.
[10]	张凡, 刘广超, 张之晗, 刘方芳, 谢琪, 高淑清. 生酮饮食对人肺癌细胞裸鼠皮下移植瘤生长的影响[J]. 癌变·畸变·突变, 2020, 32(4): 286-291.
[11]	舒智雄, 吴传城, 吴晓丽, 刘宝英. 基于SNP芯片研究PI3K/Akt/mTOR通路上自噬相关基因SNPs与胃癌的关联[J]. 癌变·畸变·突变, 2020, 32(2): 118-125,131.
[12]	马晓骉, 张麒, 潘定国. B7-H1基因rs4143815位点多态性与结直肠癌发病风险的关联研究[J]. 癌变·畸变·突变, 2019, 31(6): 440-443,448.
[13]	王兰, 张永东, 郭红云, 王涛, 王海涛, 郭欢, 杨碎胜, 李晓琴, 苏海翔. XRCC3基因多态性与西北地区妇女乳腺癌的关联性研究[J]. 癌变·畸变·突变, 2019, 31(5): 392-396,400.
[14]	应伟, 王兴远, 江波, 周伟. miR-146a多态性与非小细胞肺癌易感性的研究[J]. 癌变·畸变·突变, 2019, 31(3): 222-226.
[15]	杨谨如, 秦露露, 朱勇飞. JAK2基因突变与慢性髓系白血病易感性的meta分析[J]. 癌变·畸变·突变, 2019, 31(3): 231-237.